Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015

Mar Masiá(Universidad de Alcalá), Félix Gutiérrez(Universitat de Miguel Hernández d'Elx), José Alberto García(Universitat de Miguel Hernández d'Elx), Marta Montero, Javier García‐Abellán(Universitat de Miguel Hernández d'Elx), Marta Fernández‐González(Universitat de Miguel Hernández d'Elx), Sergio Padilla(Hospital General Universitario de Elche), José Ignacio Bernardino(Hospital Universitario La Paz), Joaquim Peraire(Instituto de Salud Carlos III), Berta Pernas(Complexo Hospitalario Universitario A Coruña)

PLoS ONE

April 26, 2019

10.1371/journal.pone.0215507

Cited by 15

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19

|JAMA|2021|728

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

|Clinical Infectious Diseases|2020|171

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

|The Lancet Infectious Diseases|2015|143